Publication:
Ivosidenib and Azacitidine in IDH1-Mutated AML.

Simple item page
dc.contributor.authorGil-Sierra, Manuel D
dc.contributor.authorBriceño-Casado, M Pilar
dc.contributor.authorSierra-Sanchez, Jesus F
dc.date.accessioned2023-05-03T13:26:57Z
dc.date.available2023-05-03T13:26:57Z
dc.date.issued2022
dc.identifier.doi10.1056/NEJMc2206489
dc.identifier.essn1533-4406
dc.identifier.pmid35767448
dc.identifier.unpaywallURLhttps://escholarship.org/content/qt8343f23c/qt8343f23c.pdf?t=rldqwn
dc.identifier.urihttp://hdl.handle.net/10668/19662
dc.issue.number26
dc.journal.titleThe New England journal of medicine
dc.journal.titleabbreviationN Engl J Med
dc.language.isoen
dc.organizationHospital Universitario de Puerto Real
dc.organizationÁrea de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
dc.organizationAGS - Jerez, Costa Noroeste y Sierra de Cáidz
dc.page.number2535-2536
dc.pubmedtypeLetter
dc.pubmedtypeComment
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshAzacitidine
dc.subject.meshGlycine
dc.subject.meshHumans
dc.subject.meshIsocitrate Dehydrogenase
dc.subject.meshLeukemia, Myeloid, Acute
dc.subject.meshPyridines
dc.titleIvosidenib and Azacitidine in IDH1-Mutated AML.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number386
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario de Puerto Real
SAS - Hospital Universitario de Jerez de la Frontera

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía